Physician profile
Deepak Kapoor
NPI 1629031539
$36,489.56
in general payments reported to CMS, 2019-2025
14 companies · $5,212 in 2025
The $5,212 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $3,825 · 2021: $446 · 2022: $700 · 2023: $6,441 · 2024: $231 · 2025: $5,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,250 · Debt Forgiveness: $5,212 · Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,250.00 |
| Debt Forgiveness | $5,211.83 |
| Food and Beverage | $421.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $14,833.18 | 2019-2023 | Provenge |
| Integra Gpo, LLC | $8,782.81 | 2019 | |
| Eagle Pharmaceuticals, INC. | $6,250.00 | 2023 | |
| Olympus America INC. | $5,211.83 | 2025 | Oes Cystonephrofiberscope |
| Janssen Biotech, INC. | $516.63 | 2019-2024 | Erleada |
| Intrinsiq Specialty Solutions, INC. | $364.27 | 2022 | |
| Accord Healthcare, INC. | $142.84 | 2023 | |
| Progenics Pharmaceuticals, INC. | $116.33 | 2022 | |
| Abbvie INC. | $96.39 | 2019 | |
| Pfizer INC. | $55.82 | 2022 | |
| Roche Diagnostics Corporation | $46.14 | 2022 | |
| Coloplast Corp | $29.06 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.84 | 2022 | |
| Ambu INC. | $20.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Kapoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.